Insulet Corporation (PODD)
undefined
undefined%
At close: undefined
271.61
1.31%
After-hours Jan 06, 2025, 07:33 PM EST

Insulet Corporation Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016
Drug Delivery Revenue 10.30M 8.70M 8.80M 10.70M 16.00M 500.00K 3.30M 14.70M 13.60M 25.90M 31.90M 15.30M 21.10M 19.10M 15.00M 21.90M 24.30M 8.30M 16.91M 14.90M 16.33M 16.56M 18.89M 17.71M 14.90M 18.25M 19.23M 17.82M 16.91M 34.76M 16.12M 14.43M
Drug Delivery Revenue Growth +18.39% -1.14% -17.76% -33.12% +3100.00% -84.85% -77.55% +8.09% -47.49% -18.81% +108.50% -27.49% +10.47% +27.33% -31.51% -9.88% +192.77% -50.92% +13.52% -8.75% -1.44% -12.32% +6.70% +18.82% -18.37% -5.07% +7.91% +5.36% -51.34% +115.58% +11.70% n/a
International Omnipod Revenue 533.60M 433.00M 501.00M 422.00M 380.50M 357.60M 366.40M 326.10M 285.80M 269.50M 275.80M 260.30M 242.10M 233.20M 231.10M 212.10M 202.00M 189.70M 192.48M 177.22M 160.81M 142.99M 132.18M 106.56M 108.68M 112.27M 102.55M 91.94M 84.80M 150.03M 78.75M 72.90M
International Omnipod Revenue Growth +23.23% -13.57% +18.72% +10.91% +6.40% -2.40% +12.36% +14.10% +6.05% -2.28% +5.95% +7.52% +3.82% +0.91% +8.96% +5.00% +6.48% -1.45% +8.61% +10.20% +12.46% +8.18% +24.05% -1.95% -3.20% +9.48% +11.54% +8.42% -43.48% +90.52% +8.03% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Non-Us Revenue 410.10M 363.00M 359.90M 308.00M 253.10M 172.02M 119.95M 71.89M
Non-Us Revenue Growth +12.98% +0.86% +16.85% +21.69% +47.13% +43.41% +66.86% n/a
United States Revenue 1.29B 942.30M 738.90M 596.40M 485.10M 391.80M 343.81M 295.10M
United States Revenue Growth +36.58% +27.53% +23.89% +22.94% +23.81% +13.96% +16.51% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 234.10M 220.00M 197.30M 212.80M 180.70M 178.70M 162.70M 144.30M 140.40M 174.40M 128.70M 121.70M 117.50M 116.30M 110.50M 130.10M 89.20M 80.80M 83.90M 81.20M 75.30M 76.55M 67.48M 65.56M 73.34M 59.33M 55.90M 61.49M 51.44M 49.97M 47.21M 49.04M 39.49M 38.79M 38.76M 56.46M 41.35M 34.67M 33.23M
Selling, General, and Administrative Revenue Growth +6.41% +11.51% -7.28% +17.76% +1.12% +9.83% +12.75% +2.78% -19.50% +35.51% +5.75% +3.57% +1.03% +5.25% -15.07% +45.85% +10.40% -3.69% +3.33% +7.84% -1.64% +13.45% +2.92% -10.60% +23.62% +6.13% -9.09% +19.55% +2.94% +5.85% -3.74% +24.18% +1.80% +0.08% -31.35% +36.55% +19.28% +4.32% n/a
Research and Development Revenue 54.90M 53.90M 50.20M 42.00M 57.80M 55.10M 50.10M 49.50M 45.00M 42.60M 43.10M 41.80M 37.50M 40.10M 40.70M 38.30M 38.80M 34.20M 35.50M 34.70M 30.78M 32.26M 31.95M 28.51M 21.76M 18.42M 19.91M 18.78M 20.14M 18.03M 17.50M 16.03M 13.73M 12.95M 12.99M 12.90M 10.04M 12.07M 8.21M
Research and Development Revenue Growth +1.86% +7.37% +19.52% -27.34% +4.90% +9.98% +1.21% +10.00% +5.63% -1.16% +3.11% +11.47% -6.48% -1.47% +6.27% -1.29% +13.45% -3.66% +2.31% +12.74% -4.60% +0.97% +12.06% +31.03% +18.16% -7.50% +6.02% -6.75% +11.71% +3.02% +9.14% +16.75% +6.03% -0.28% +0.71% +28.52% -16.85% +47.06% n/a

Create Price Alert on PODD

Your price alert will notify you when the stock price is above 268.11.

Add to Watchlist